Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × Midazolam × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 2 Advanced Malignancies 2 Urothelial Cancer 1 Thyroid Neoplasms 1 Solid Tumors, KRAS Mutation 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Opioid-Related Disorders 1 Neoplasms 1 Melanoma 1 Leiomyosarcoma 1 KRAS p.G12C Mutant Advanced Solid Tumors 1 Healthy Adult Participants 1 Glioma 1 Cancer Pain 1 Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 5 Biopsy 4 X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 selpercatinib 2 erdafitinib 2 entrectinib 2 ensartinib 2 Radiotherapy 2 Nivolumab 2 Lomustine 2 Etoposide 2 Cyclophosphamide 2 Carboplatin 2 ulixertinib 1 tipifarnib 1 tazemetostat 1 regorafenib 1 perillyl alcohol 1 pemigatinib 1 pembrolizumab 1 pegfilgrastim 1 palbociclib 1 olaparib 1 niraparib 1 lenvatinib 1 larotrectinib 1 ivosidenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡